Skip to content

Welcome to the 60th
EMWA Conference!

We are delighted to welcome you to the 60th EMWA Conference, taking place virtually this autumn. As we mark this milestone event, we invite you to join us online for a rich and flexible programme designed to support medical writers at every stage of their careers.
Booking is for EMWA members

Browse and fill a basket without an account. You must sign in as a member before you can check out.

«Back to the programme
WorkshopFoundationDDF17a · 1 EPDP credits

DDF17a – Ethical Issues in Clinical Trials

Wednesday 18 November 2026 · 13:30-17:00 CET · Art Gertel

Who it is for

This workshop is intended for medical writers (and others) who are interested in clinical trials and would like to know more about the evolution of ethical principles associated with human subject participation.

What it covers

Global ethical aspects that are taken into consideration for studies will be reviewed. In addition, case examples of situational clinical trial and medical ethics will be provided for interactive discussion.
This workshop will consist of a combination of presentations on relevant ethical issues, with respect to clinical trials, and group discussions on challenging ethical considerations of some “real-world” case studies. The presentations will focus on the importance of ethics in GCP, the informed consent process, and the challenges that may arise in developing countries. Practical experience will be shared with the participants.

Workshop leaders
Art Gertel

Art has a background in neurophysiology and behavioural medicine. As an independent consultant, he specialises in regulatory strategy, Data Safety Monitoring Board management, medical writing, and bioethics. Art has held senior posts at a
number of companies including Schering-Plough/Merck, Hoffmann-LaRoche, TFS,
and Quintiles, and headed departments responsible for medical writing, publications, project management, and regulatory affairs. He also served as a Senior Research
Fellow with the Centre for Innovation in Regulatory Sciences (CIRS). Art has extensive teaching experience and has presented to professional organisations (e.g. EMWA, AMWA, DIA), and corporate and academic audiences, worldwide. He spent 2 years heading Clinical Operations for an eDC ‘dot.com’ company, and has been active in CDISC since its inception. He served as Chair of the Global Ethics and Regulatory Initiative (GERI) of the Alliance for Clinical Research Excellence and

Safety (ACRES). He is a Founding Member of the Global Alliance of Publication
Professionals (GAPP), a Past President of AMWA, and a Fellow of both AMWA and EMWA. Art served in a Senior Advisory capacity on the Budapest Working Group in developing the CORE Reference. He has a particular interest in bioethics in the
context of clinical studies, is an advisor to an IRB, and serves on a number of task forces focusing on improving the drug development process while protecting the rights and safety of clinical study participants.

Back To Top
Your Cart

Your cart is empty.